Transparency Market Research
Autologous Cell Therapy Market Estimated to Grow USD 34.7 Billion by 2027, Rising at a 18.1% CAGR- Transparency Market Research, Inc.
August 21, 2024 11:09 ET | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. , Aug. 21, 2024 (GLOBE NEWSWIRE) -- According to Transparency Market Research (TMR), the global autologous cell therapy market...
Acclaimed Cardiology
Acclaimed Cardiology Expert Dr. Peter Libby To Keynote 19th Annual CMHC, Revolutionize Atherosclerosis Care
May 22, 2024 11:00 ET | Cardiometabolic Health Congress
Boca Raton, FL, May 22, 2024 (GLOBE NEWSWIRE) -- The Cardiometabolic Health Congress (CMHC) is proud to announce that one of the foremost authorities in atherosclerosis, Peter Libby, MD, will...
Verve-Logo-RGB-Color-wTrademark.png
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
November 07, 2023 06:30 ET | Verve Therapeutics
U.S. Food and Drug Administration (FDA) Clears Investigational New Drug Application for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia (HeFH) Collaboration with Eli Lilly and...
MSP Turbo II™ Vaporizers: Next Generation of Vapor Delivery Solutions for CVD and ALD Processes
MSP Unveils Turbo II™ Vaporizers
November 06, 2023 12:25 ET | MSP, a Division of TSI
Shoreview, MN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- MSP, a Division of TSI®, is thrilled to announce the launch of the new line of MSP Turbo II™ Vaporizers. Engineered for chemical vapor deposition...
Verve-Logo-RGB-Color-wTrademark.png
Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3
October 31, 2023 06:01 ET | Verve Therapeutics
BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene...
TIP_link_300x300.jpg
Transdermal Drug Delivery System Market to Hit 4.3% CAGR with Transdermal Gels Segment Driving Growth During 2022–2030 | The Insight Partners
October 25, 2023 10:40 ET | The Insight Partners
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Transdermal drug delivery systems are dosage forms actively used to deliver a therapeutically effective amount of drug across a patient’s skin. It is a...
AMR Logo.png
Cardiovascular Digital Solutions Market to Reach $154.1 Billion, by 2032 at 6.2% CAGR: Allied Market Research
September 04, 2023 08:38 ET | Allied Market Research
New Castle, Delaware, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Cardiovascular Digital Solutions Market by Service (Unobtrusive Monitoring, CVD Health...
Global Chemical Vapor Deposition Market
Chemical Vapor Deposition Global Market Report 2023: Growth in Solar and Photovoltaic Cells Drives $40 Billion Industry
April 12, 2023 08:13 ET | Research and Markets
Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Chemical Vapor Deposition Market Size, Share & Trends Analysis Report By Category (CVD Equipment), By Application (Semiconductor &...
Vantage Market Research.png
Digital Therapeutics Market Projected to Hit $14.52 Billion by 2028 growing at 28.1% CAGR | Vantage Market Research
March 08, 2023 12:38 ET | Vantage Market Research
WASHINGTON, March 08, 2023 (GLOBE NEWSWIRE) -- The global Digital Therapeutics Market is experiencing significant growth, and it is expected to continue to expand rapidly in the coming years....
Corline Biomedical A
Corline Biomedical AB: Tecknar samarbetsavtal för CHS™-coatning av bypassgraft med ambition att starta kliniska studier 2023
February 17, 2023 12:00 ET | Corline Biomedical AB
Corline har tecknat ett utvecklings- och samarbetsavtal med en europeisk leverantör av kärlgrafter för bypassoperationer som används vid kirurgi för patienter med hjärtinfarkt. Avtalet reglerar...